ER-positive breast cancer patients with more than three positive nodes or grade 3 tumors are at high risk of late recurrence after 5-year adjuvant endocrine therapy

PURPOSE: Currently, although several clinical trials available give strong suggestions that extension of endocrine therapy has benefits, the risk level at which patients may benefit from extended endocrine therapy remains uncertain. This study aimed to identify the proportion of patients at a substa...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Onco Targets Ther
Hlavní autoři: Song, Fangbin, Zhang, Jianbing, Li, Shanbao, Wu, Junyi, Jin, Tao, Qin, Jun, Wang, Ye, Wang, Min, Xu, Junming
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5633314/
https://ncbi.nlm.nih.gov/pubmed/29042797
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S142698
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky